Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda crawled time : 00:00 save search
Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA
Published: 2024-03-31 (Crawled : 00:00) - prnewswire.com
BIIB | $192.68 1.13% 590K
|
Health Technology
|
| O: -0.88%
H: 0.0%
C: 0.0%
leqembi fda disease license treatment alzheimer's application submission
Treadwell Announces Ocifisertib, a First-in-Class PLK4 Inhibitor, has Received Orphan Designation from U.S. FDA for the Treatment of Acute Myeloid Leukemia
Published: 2024-02-20 (Crawled : 00:00) - biospace.com/
TCON | $2.08 -1.42% 88K
|
Health Technology
|
| O: -2.57%
H: 4.4%
C: 2.25%
fda treatment designation leukemia
FDA Advisory Committee Votes in Favor of Abbott's First-of-Its-Kind TriClip™ System to Treat People With a Leaky Tricuspid Heart Valve
Published: 2024-02-13 (Crawled : 00:00) - prnewswire.com
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: -0.83%
H: 0.66%
C: 0.38%
fda treat system heart
Court Orders FDA to Resolve Vanda Pharmaceuticals' Jet Lag Hearing Request by March 5, 2024
Published: 2024-01-30 (Crawled : 00:00) - prnewswire.com
VNDA | $5.025 1.11% 890K
|
Health Technology
|
| O: 0.0%
H: 0.26%
C: -3.95%
fda resolve
Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients
Published: 2024-01-18 (Crawled : 00:00) - biospace.com/
HOTH | $1.22 3.39% 4.6K
|
Health Technology
|
| O: 5.43%
H: 13.24%
C: 0.74%
ht-001 fda approval treat trial therapeutics
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors
Published: 2024-01-08 (Crawled : 00:00) - biospace.com/
NUVB A | $2.645 2.52% 580K
|
|
| O: 0.67%
H: 4.0%
C: 3.33%
nuv-1511 fda drug tumors treatment clearance application advanced
Masimo Receives FDA Clearance for Stork™ Baby Monitoring System
Published: 2023-12-18 (Crawled : 00:00) - biospace.com/
MASI | $134.69 -0.91% 120K
|
Health Technology
|
| O: 0.0%
H: 6.06%
C: 3.16%
fda clearance system baby
FDA Approves Bio-Thera Solutions' Avzivi® (bevacizumab-tnjn), a biosimilar referencing Avastin®
Published: 2023-12-07 (Crawled : 00:00) - biospace.com/
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: -0.97%
H: 0.3%
C: -0.19%
avzivi fda biosimilar
Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH
Published: 2023-12-06 (Crawled : 00:00) - globenewswire.com
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: 0.52%
H: 0.18%
C: -0.43%
fabhalta fda first approval offering novartis
Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis
Published: 2023-11-30 (Crawled : 00:00) - biospace.com/
BIOR | $0.6078 1.38% 69K
|
Health Care and Social Assistan...
|
| O: 3.31%
H: 2.4%
C: -0.8%
bt-600 fda treatment clearance application therapeutics
FDA Safety Communication Does Not Impact BD Syringes
Published: 2023-11-30 (Crawled : 00:00) - prnewswire.com
BDX | $235.01 0.8% 330K
|
Health Technology
|
| O: -0.05%
H: 1.03%
C: 0.92%
fda communication impact
FDA Launches Probe of Malignancies Linked to CAR-T Therapies
Published: 2023-11-28 (Crawled : 00:00) - biospace.com/
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
fda car-t
HUTCHMED Announces that Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) for Previously Treated Metastatic Colorectal Cancer
Published: 2023-11-09 (Crawled : 00:00) - globenewswire.com
HCM | $16.53 1.04% 19K
|
Health Technology
|
| O: -1.69%
H: 0.68%
C: -5.63%
fda approval cancer
Ocular Therapeutix™ Receives FDA Agreement Under Special Protocol Assessment (SPA) for its First Pivotal Clinical Trial of OTX-TKI in Wet AMD
Published: 2023-11-01 (Crawled : 00:00) - biospace.com/
OCUL | News | $5.165 -11.86% 5.1M
|
Health Technology
|
| O: 3.86%
H: 16.89%
C: 7.77%
fda ocular trial agreement
Everest Medicines' Licensing Partner Pfizer Announces U.S. FDA Approves Etrasimod for Adults with Moderately to Severely Active Ulcerative Colitis
Published: 2023-10-15 (Crawled : 00:00) - prnewswire.com
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: 2.24%
H: 3.32%
C: 1.34%
CALT | News | $17.65 3K
|
Health Technology
|
| O: 2.19%
H: 1.47%
C: -3.78%
fda active
Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal BoostThe first of the TULSA AI modules, Thermal Boost enables predictable, customized ablation at the prostate capsule
Published: 2023-09-25 (Crawled : 00:00) - biospace.com/
PROF | $7.85 -5.42% -5.73% 17K
|
Health Technology
|
| O: 0.9%
H: 0.79%
C: -1.98%
pro fda clearance medical
U.S. FDA Approves ABRYSVO™, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Infants Through Active Immunization of Pregnant Individuals 32-36 Weeks of Gestational Age
Published: 2023-08-21 (Crawled : 00:00) - biospace.com/
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: 0.14%
H: 1.3%
C: 0.82%
fda active vaccine respiratory virus
Accuray Receives FDA Clearance for VitalHold™ on the Radixact® System; Breast Cancer Treatment Option Will Also Be Available in the EU Market
Published: 2023-08-10 (Crawled : 00:00) - prnewswire.com
ARAY | $2.16 -2.26% 270K
|
Health Technology
|
| O: -7.94%
H: 0.0%
C: -15.09%
radixact fda breast cancer treatment clearance market
FDA Grants Traditional Approval for LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer's Disease
Published: 2023-07-07 (Crawled : 00:00) - prnewswire.com
BIIB | $192.68 1.13% 590K
|
Health Technology
|
| O: 0.21%
H: 0.34%
C: -3.68%
leqembi fda disease approval treatment alzheimer's grants
FDA Approves ARUP Laboratories' AAV5 DetectCDx™, a First-Ever Companion Diagnostic Immunoassay for a Gene Therapy
Published: 2023-06-30 (Crawled : 00:00) - prnewswire.com
BMRN S | $88.95 -1.24% 500K
|
Health Technology
|
| O: 1.2%
H: 1.97%
C: -3.69%
fda diagnostic companion therapy
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
INSG | $2.98 23.14% 190K
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.